Biolexis Secures $10M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from David Bearss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by...
Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by chronic inflammation and neurodegeneration, today announced that the company has been awarded first place in...
Halia Therapeutics believes it is on the forefront of research to target chronic inflammation to treat neurodegeneration and inflammatory diseases. Chronic inflammation causes more health issues than the average person may realize. It causes arthritis, anemia, Alzheimer’s, bone marrow disorders and many other diseases. Started in 2017, Halia Therapeutics has now expanded to a new […]
/PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by...